Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jth.15420 http://scihub22266oqcxt.onion/10.1111/jth.15420 34105247!8237075!34105247     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Thromb+Haemost 2021 ; 19 (9): 2314-2317 Nephropedia Template TP {{tp|p=34105247|t=2021. Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine |pdf=|usr=}}{{34105247}} gab.com Text Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine JO: J Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=34105247 #FOAvip BACKGROUND: In December 2020 the Israeli Health Ministry began a mass vaccination campaign with the BNT162b2 vaccine. This was an important step in overcoming the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic. Autoimmune phenomenon have been described after receiving vaccinations. PATIENTS/METHODS: Here we describe a case series of patients who developed acquired Thrombotic Thrombocytopenic Purpura, a rare autoimmune disease, within several days of receiving the BNT162b2 vaccine. CONCLUSIONS: A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) activity should be evaluated in patients with history of aTTP before and after any vaccination, especially the SARS-CoV-2 vaccination, and immunosuppression treatment should be considered before vaccination in cases of low ADAMTS13 activity. Patients should be closely monitored after the vaccine for clinical situation and laboratory data. Post vaccination thrombocytopenia assessment should include immune thrombocytopenic purpura, vaccine-induced immune thrombotic thrombocytopenia and acquired thrombotic thrombocytopenic purpura. Twit Text FOAVip Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine ????J Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=34105247 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34105247 #FOAvip English Wikipedia <ref>{{Cite pmid|34105247}}</ref> Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine #MMPMID34105247 Maayan H; Kirgner I; Gutwein O; Herzog-Tzarfati K; Rahimi-Levene N; Koren-Michowitz M; Blickstein D J Thromb Haemost 2021[Sep]; 19 (9): 2314-2317 PMID34105247show ga BACKGROUND: In December 2020 the Israeli Health Ministry began a mass vaccination campaign with the BNT162b2 vaccine. This was an important step in overcoming the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic. Autoimmune phenomenon have been described after receiving vaccinations. PATIENTS/METHODS: Here we describe a case series of patients who developed acquired Thrombotic Thrombocytopenic Purpura, a rare autoimmune disease, within several days of receiving the BNT162b2 vaccine. CONCLUSIONS: A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) activity should be evaluated in patients with history of aTTP before and after any vaccination, especially the SARS-CoV-2 vaccination, and immunosuppression treatment should be considered before vaccination in cases of low ADAMTS13 activity. Patients should be closely monitored after the vaccine for clinical situation and laboratory data. Post vaccination thrombocytopenia assessment should include immune thrombocytopenic purpura, vaccine-induced immune thrombotic thrombocytopenia and acquired thrombotic thrombocytopenic purpura. |*COVID-19[MESH] |*Purpura, Thrombocytopenic, Idiopathic/chemically induced/diagnosis[MESH] |*Purpura, Thrombotic Thrombocytopenic/chemically induced/diagnosis[MESH] |ADAMTS13 Protein[MESH] |BNT162 Vaccine[MESH] |COVID-19 Vaccines[MESH] |Humans[MESH] |Rare Diseases[MESH]Acquired thrombotic thrombocytopenic purpura: A rare disease associate(epmc).pdf DeepDyve Pubget Overpricing